CBLL
CeriBell, Inc.
NASDAQ · USHealthcareMedical - Devices
$18.43-1.55%
Price as of Jul 20, 2026
CBLL financials
CeriBell, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $89.1M | $65.4M | $45.2M | $25.9M |
| Cost of revenue | $10.8M | $8.7M | $7.1M | $4.4M |
| Gross profit | $78.3M | $56.8M | $38.2M | $21.5M |
| Operating expenses | $136.7M | $96.5M | $68.2M | $57.5M |
| Operating income | -$58.4M | -$39.7M | -$30.0M | -$36.0M |
| Net income | -$53.4M | -$40.5M | -$29.5M | -$37.2M |
| EBITDA | -$50.2M | -$37.3M | -$26.5M | -$35.1M |
| Basic EPS | $-1.46 | $-3.39 | $-1.26 | $-1.59 |
| Diluted EPS | $-1.46 | $-3.39 | $-1.26 | $-1.59 |
| Balance sheet | ||||
| Cash & equivalents | $40.5M | $194.4M | $34.5M | $68.2M |
| Total assets | $195.8M | $225.4M | $58.9M | $86.5M |
| Total liabilities | $40.5M | $34.2M | $171.2M | $172.9M |
| Stockholders’ equity | $155.3M | $191.2M | -$112.3M | -$86.4M |
| Total debt | $22.3M | $22.0M | $14.2M | $18.2M |
| Net debt | -$18.2M | -$172.4M | -$20.3M | -$50.0M |
| Cash flow | ||||
| Operating cash flow | -$40.8M | -$35.0M | -$29.2M | -$32.0M |
| Capital expenditure | -$767.0K | -$1.3M | -$983.0K | -$516.0K |
| Free cash flow | -$41.6M | -$36.4M | -$30.1M | -$32.5M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |